The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation

T Ettl; S Schwarz-Furlan; F Haubner; S Muller; J Zenk; Martin Gosau; TE Reichert; K Zeitler

doi:10.1016/j.oraloncology.2012.02.021

The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation

T Ettl, S Schwarz-Furlan, F Haubner, S Muller, J Zenk, Martin Gosau (Co-Autor/-in), TE Reichert, K Zeitler

Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung

42 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	822-830
Fachzeitschrift	ORAL ONCOLOGY
Jahrgang	48
Ausgabenummer	9
DOIs	https://doi.org/10.1016/j.oraloncology.2012.02.021
Publikationsstatus	Veröffentlicht - 2012

Zugriff auf Dokument

10.1016/j.oraloncology.2012.02.021

Dieses zitieren

@article{da614273672044098d8184f163860194,

title = "The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation",

keywords = "AKT EXPRESSION, BREAST-CANCER, TRANSCRIPTION FACTOR, PHOSPHORYLATED AKT, GASTRIC-CANCER, LUNG-CANCER, CARCINOMA, INVASION, TRANSLOCATION, TRANSLATION",

author = "T Ettl and S Schwarz-Furlan and F Haubner and S Muller and J Zenk and Martin Gosau and TE Reichert and K Zeitler",

note = "Department of Oral and Maxillofacial Surgery, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; Department of Pathology, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; Department of Pathology, University of Erlangen-Nuremberg, Krankenhausstrasse 10, 91054 Erlangen, Germany; Department of Otorhinolaryngology, University of Erlangen-Nuremberg, Waldstrasse 1, 91054 Erlangen, Germany; Department of Otorhinolaryngology, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany",

year = "2012",

doi = "10.1016/j.oraloncology.2012.02.021",

language = "English",

volume = "48",

pages = "822--830",

journal = "ORAL ONCOLOGY",

issn = "1368-8375",

number = "9",

}

TY - JOUR

T1 - The PI3K/AKT/mTOR signalling pathway is active in salivary gland cancer and implies different functions and prognoses depending on cell localisation

AU - Ettl, T

AU - Schwarz-Furlan, S

AU - Haubner, F

AU - Muller, S

AU - Zenk, J

AU - Gosau, Martin

AU - Reichert, TE

AU - Zeitler, K

N1 - Department of Oral and Maxillofacial Surgery, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; Department of Pathology, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; Department of Pathology, University of Erlangen-Nuremberg, Krankenhausstrasse 10, 91054 Erlangen, Germany; Department of Otorhinolaryngology, University of Erlangen-Nuremberg, Waldstrasse 1, 91054 Erlangen, Germany; Department of Otorhinolaryngology, University of Regensburg, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany

PY - 2012

Y1 - 2012

KW - AKT EXPRESSION

KW - BREAST-CANCER

KW - TRANSCRIPTION FACTOR

KW - PHOSPHORYLATED AKT

KW - GASTRIC-CANCER

KW - LUNG-CANCER

KW - CARCINOMA

KW - INVASION

KW - TRANSLOCATION

KW - TRANSLATION

U2 - 10.1016/j.oraloncology.2012.02.021

DO - 10.1016/j.oraloncology.2012.02.021

M3 - Original Article

C2 - 22445095

SN - 1368-8375

VL - 48

SP - 822

EP - 830

JO - ORAL ONCOLOGY

JF - ORAL ONCOLOGY

IS - 9

ER -